Kim A. Reiss Binder, MD, spoke about the use of niraparib plus either nivolumab or ipilimumab for patients with platinum-sensitive advanced pancreatic adenocarcinoma.
Kim A. Reiss Binder, MD
Advertisement
Articles by Kim A. Reiss Binder, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants RMAT Designation to RZ-001 in Advanced Hepatocellular Carcinoma
2
Novel HP1K Inhibitor Shows Favorable Responses in ccRCC, Solid Tumors
3
What Does the Future Hold for Immune Effector Cell Therapies?
4
Patient Reported Outcomes and Quality of Life Considerations
5